ading Many thanks for your post, Guts. A well-dire
Post# of 7769
At the end of a visit to this board I find myself with more energy, not less. On some boards where bashers abound, a reader will wind up bracing for the next air pocket and the sense of losing height.
During the phone call it was good to find concurrence on the notion that pharma products and their distribution, but also biotech innovation can offer unique opportunities. In the case of Scrips, if revenues in China are able to to build as well as in the US and South America, or possibly even better, that will allow the company to develop on a worldwide scale that I see as finding representation in Japan, Indonesia and Thailand by 2015.